Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.

Saved in:
Bibliographic Details
Title: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
Authors: Karnes JH; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.; Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA., Rettie AE; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA., Somogyi AA; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia., Huddart R; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Fohner AE; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA., Formea CM; Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA., Ta Michael Lee M; Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA., Llerena A; INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain., Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.; Department of Medicine, Stanford University, Stanford, California, USA., Phillips EJ; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mintzer S; Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Callaghan JT; Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 302-309. Date of Electronic Publication: 2020 Sep 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32779747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Karnes+JH%22">Karnes JH</searchLink>; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.; Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Rettie+AE%22">Rettie AE</searchLink>; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Somogyi+AA%22">Somogyi AA</searchLink>; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Huddart+R%22">Huddart R</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Fohner+AE%22">Fohner AE</searchLink>; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Formea+CM%22">Formea CM</searchLink>; Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Ta+Michael+Lee+M%22">Ta Michael Lee M</searchLink>; Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Llerena+A%22">Llerena A</searchLink>; INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain.<br /><searchLink fieldCode="AU" term="%22Whirl-Carrillo+M%22">Whirl-Carrillo M</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Klein+TE%22">Klein TE</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.; Department of Medicine, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+EJ%22">Phillips EJ</searchLink>; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Mintzer+S%22">Mintzer S</searchLink>; Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gaedigk+A%22">Gaedigk A</searchLink>; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Caudle+KE%22">Caudle KE</searchLink>; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Callaghan+JT%22">Callaghan JT</searchLink>; Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 302-309. <i>Date of Electronic Publication: </i>2020 Sep 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32779747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.2008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 302
    Titles:
      – TitleFull: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Karnes JH
      – PersonEntity:
          Name:
            NameFull: Rettie AE
      – PersonEntity:
          Name:
            NameFull: Somogyi AA
      – PersonEntity:
          Name:
            NameFull: Huddart R
      – PersonEntity:
          Name:
            NameFull: Fohner AE
      – PersonEntity:
          Name:
            NameFull: Formea CM
      – PersonEntity:
          Name:
            NameFull: Ta Michael Lee M
      – PersonEntity:
          Name:
            NameFull: Llerena A
      – PersonEntity:
          Name:
            NameFull: Whirl-Carrillo M
      – PersonEntity:
          Name:
            NameFull: Klein TE
      – PersonEntity:
          Name:
            NameFull: Phillips EJ
      – PersonEntity:
          Name:
            NameFull: Mintzer S
      – PersonEntity:
          Name:
            NameFull: Gaedigk A
      – PersonEntity:
          Name:
            NameFull: Caudle KE
      – PersonEntity:
          Name:
            NameFull: Callaghan JT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2021 Feb
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 109
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1